Algert Global’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-33,570
| Closed | -$35K | – | 1205 |
|
|
2024
Q4 | $35K | Buy |
+33,570
| New | +$35K | ﹤0.01% | 1147 |
|
|
2022
Q3 | – | Sell |
-30,340
| Closed | -$56K | – | 1200 |
|
|
2022
Q2 | $56K | Buy |
+30,340
| New | +$56K | ﹤0.01% | 1147 |
|
|
2020
Q1 | – | Sell |
-32,403
| Closed | -$269K | – | 428 |
|
|
2019
Q4 | $269K | Buy |
32,403
+11,560
| +55% | +$96K | 0.08% | 276 |
|
|
2019
Q3 | $154K | Sell |
20,843
-28,280
| -58% | -$209K | 0.06% | 298 |
|
|
2019
Q2 | $551K | Buy |
+49,123
| New | +$551K | 0.2% | 159 |
|
|
2019
Q1 | – | Sell |
-75,586
| Closed | -$1.14M | – | 332 |
|
|
2018
Q4 | $1.14M | Buy |
75,586
+8,777
| +13% | +$132K | 0.32% | 111 |
|
|
2018
Q3 | $1.24M | Buy |
66,809
+45,159
| +209% | +$835K | 0.27% | 141 |
|
|
2018
Q2 | $495K | Buy |
21,650
+350
| +2% | +$8K | 0.1% | 244 |
|
|
2018
Q1 | $606K | Sell |
21,300
-29,933
| -58% | -$852K | 0.12% | 233 |
|
|
2017
Q4 | $1.08M | Buy |
51,233
+5,380
| +12% | +$114K | 0.26% | 158 |
|
|
2017
Q3 | $833K | Buy |
45,853
+11,050
| +32% | +$201K | 0.19% | 183 |
|
|
2017
Q2 | $539K | Buy |
+34,803
| New | +$539K | 0.15% | 213 |
|